United Kingdom Hysteroscopy Procedures Market Size, Share By CPT Codes (CPT Code 58555, CPT Code 58558, CPT Code 58562, CPT Code 58340, and CPT Code 58563), By End-Use (Hospitals, Clinics), United Kingdom Hysteroscopy Procedures Market Insights, Industry Trend, Forecasts to 2035.

United Kingdom Hysteroscopy Procedures Market Insights Forecasts to 2035

• United Kingdom Hysteroscopy Procedures Market Size 2024: USD 107.5 Mn
• United Kingdom Hysteroscopy Procedures Market Size 2035:  USD 251.7 Mn
• United Kingdom Hysteroscopy Procedures Market CAGR 2024: 8.04%
• United Kingdom Hysteroscopy Procedures Market Segments: CPT Codes and End-Use

The United Kingdom Hysteroscopy Market Size is Growing as part of the wider industry associated with Women’s Health and Minimal Invasive Surgery, which includes both diagnostic and operative Hysteroscopy systems, Fluid Management Devices and Surgical Instruments. This increased hysteroscopy procedural volume is attributed to various factors: gynaecological issues such as Abnormal Uterine Bleeding and Infertility, an increase in older females in the UK; large NHS support/commitment to Patient-Day Cases and Out-Patients Procedures, additional benefits associated with established Clinical Guidelines. Furthermore, the UK Hysteroscopy Market continues to evolve from Traditional Inpatient Models toward Office-Based Hysteroscopy Models. This transition continues to improve the quality and efficiency of the UK Hysteroscopy market by introducing Advanced Visualization Techniques and Single Use Devices to the industry, as well as Digital Imaging Systems, and all changed due to Healthcare Modernization, Hospital Efficiency Targets and Government Regulations and Reimbursement Policies are clarified and enhanced.

The UK government allocated EURO 25 million between 2023 and 2025 to expand one-stop women’s health hubs, aiming to integrate services for conditions such as abnormal uterine bleeding and menopause. These hubs reduce pressure on secondary care and improve access to diagnostic procedures, including outpatient hysteroscopy, supporting earlier diagnosis and streamlined women’s healthcare pathways.

The UK hysteroscopy market is expected to see a significant increase in revenue from the increasing prevalence of conditions affecting the female reproductive system, to rising numbers of older females seeking hysteroscopy services, and to the ongoing trend toward the use of less invasive techniques when performing hysteroscopies. In addition, innovation in technology such as improved images, single-use instrumentation, electronic imaging systems, and artificial intelligence related to the interpretation of images and patient management will create an expanding number of opportunities for outpatient and office-based hysteroscopic procedures. Areas of growth in this sector include Diagnostic and Operative Hysteroscopy, related to Fertility Services, and Same-Day Treatment Pathways, enabled by improvements in the National Health Service's (NHS) operational efficiency, enhancements in hospital facilities, and clinical guidelines that encourage faster Diagnosis and Decreased In-patient Admissions, despite continuing Financial Pressures on Hospital Systems.

Market Dynamics of the United Kingdom Hysteroscopy Procedures Market

The UK hysteroscopy procedures market, is driven by the increasing age of the female population, an increasing prevalence of gynecological conditions, a commitment from the NHS to support minimally invasive services, and continued investments into women's health. An increasing focus on high-value outpatient and office-based placement of hysteroscopy means that the development of enhanced visualization, the availability of disposable hysteroscopies, and the ongoing evolution of fluid management systems are changing treatment pathways and enhancing efficiencies. The greater presence of hospital and community care facilities combined with increased awareness of health and supportive clinical guidelines are driving greater demand for both diagnostic and operative hysteroscopy. Due to this momentum, the UK is establishing itself as a key target for International device manufacturers and drawing investments into digital imaging, disposable hysteroscopes, and AI-enabled diagnostic solutions.

The United Kingdom hysteroscopy procedures market faces restraints such as budget constraints within the NHS, cost-containment pressures on medical devices, and strict regulatory and clinical governance requirements. Additional challenges include workforce shortages in gynecology, limited procedure capacity, variability in regional access, and cautious adoption of new technologies, which can slow innovation and limit profitability despite rising demand for minimally invasive diagnostic and operative hysteroscopy.

The UK hysteroscopy procedure market is on the rise and has growing demand for gynae procedures, expanding NHS services and ongoing technology development. High-definition images, single use/office-based hysteroscopes, digital fluid control and AI-assisted visualization are all providing additional types of growth opportunities. Overall, healthcare technology advancements are improving outpatient care pathways; expanding women's health hubs; and creating efficiencies in procedural access, experience and clinical outcomes for patients in the minimally invasive gynecological market throughout the UK.

Market Segmentation

The United Kingdom hysteroscopy procedures market share is classified into CPT codes and end-use.

By CPT Codes

The United Kingdom hysteroscopy procedures market is divided by cpt codes into cpt code 58555, cpt code 58558, cpt code 58562, cpt code 58340, and cpt code 58563. Among these, the, cpt code 58558 segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is driven by high prevalence of abnormal bleeding, fibroids, and polyps, making it a common diagnostic and therapeutic procedure.

By End-Use

The United Kingdom hysteroscopy procedures market is divided by end-use into hospitals, clinics. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because the hospitals possess the sophisticated medical infrastructure and specialized equipment required for operative hysteroscopy, which accounts for the majority of the market.

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the United Kingdom hysteroscopy procedures market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in United Kingdom Hysteroscopy Procedures Market

• KARL STORZ SE & Co. KG
• Stryker Corporation
• Delmont Imaging
• Medtronic
• CooperCompanies
• Johnson & Johnson (Ethicon, Inc.)
• Richard Wolf GmbH
• B. Braun Melsungen AG
• Olympus Corp.
• Hologic, Inc.
• Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom hysteroscopy procedures market based on the below-mentioned segments:

United Kingdom Hysteroscopy Procedures Market, By CPT Codes

• CPT Code 58555
• CPT Code 58558
• CPT Code 58562
• CPT Code 58340
• CPT Code 58563

United Kingdom Hysteroscopy Procedures Market, By End-Use

• Hospitals
• Clinics.